dr. choueiri discusses avelumab/axitinib data in rcc
Published 5 years ago • 385 plays • Length 1:47Download video MP4
Download video MP3
Similar videos
-
1:38
dr. choueiri on avelumab plus axitinib in mrcc
-
1:37
dr. shuch on caveats of avelumab/axitinib combination in rcc
-
1:47
dr. choueiri discusses immunotherapy in rcc
-
0:51
dr. choueiri discusses the cantata trial in rcc
-
0:57
avelumab and axitinib for the treatment of advanced rcc
-
3:18
exploring the combination of first-line avelumab/axitinib in hcc
-
2:09
dr. choueiri on biomarkers in rcc
-
1:41
dr. choueiri on next steps for treatment in rcc
-
0:52
dr. choueiri on the role of cabozantinib in rcc
-
4:39
avelumab and axitinib vs sunitinib in treating advanced renal cell carcinoma
-
1:53
dr. choueiri discusses checkpoint inhibitors in rcc
-
1:47
dr. choueiri on the impact of the javelin renal 101 findings in rcc
-
1:06
dr. choueiri on atezolizumab plus bevacizumab in non–clear cell rcc
-
1:40
dr. choueiri on checkpoint inhibitor/tki combinations in rcc
-
3:22
biomarker analysis from javelin renal 101: avelumab plus axitinib versus sunitinib in arcc
-
13:19
esmo 2019: dr. choueiri discusses novel treatment strategies in gu cancers
-
1:02
dr. choueiri on the research with immunotherapy in rcc
-
1:03
dr. hutson discusses the phase iii atlas study in rcc
-
1:00
pembrolizumab/axitinib and avelumab/axitinib combo for rcc